Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Acute eosinophilic hepatitis from trovafloxacin.

× No keyword cloud information.

12 in total

Review 1. Idiosyncratic drug-induced liver injury and the role of inflammatory stress with an emphasis on an animal model of trovafloxacin hepatotoxicity.

Authors: Patrick J Shaw; Patricia E Ganey; Robert A Roth
Journal: Toxicol Sci Date: 2010-06-10 Impact factor: 4.849

2. Drug-Induced Liver Disease.

Authors:
Journal: Curr Treat Options Gastroenterol Date: 2000-12

3. Clinical and histopathologic features of fluoroquinolone-induced liver injury.

Authors: Eric S Orman; Hari S Conjeevaram; Raj Vuppalanchi; James W Freston; James Rochon; David E Kleiner; Paul H Hayashi
Journal: Clin Gastroenterol Hepatol Date: 2011-02-26 Impact factor: 11.382

4. Eosinophils mediate the pathogenesis of halothane-induced liver injury in mice.

Authors: William R Proctor; Mala Chakraborty; Lynette S Chea; Jeffrey C Morrison; Julia D Berkson; Kenrick Semple; Mohammed Bourdi; Lance R Pohl
Journal: Hepatology Date: 2013-03-15 Impact factor: 17.425

5. Trovafloxacin hepatotoxicity.

Authors: D A Lazarczyk; N S Goldstein; S C Gordon
Journal: Dig Dis Sci Date: 2001-04 Impact factor: 3.199

6. Safety of fluoroquinolones: An update.

Authors: L Mandell; G Tillotson
Journal: Can J Infect Dis Date: 2002-01

7. Tumor necrosis factor alpha is a proximal mediator of synergistic hepatotoxicity from trovafloxacin/lipopolysaccharide coexposure.

Authors: Patrick J Shaw; Patricia E Ganey; Robert A Roth
Journal: J Pharmacol Exp Ther Date: 2008-09-26 Impact factor: 4.030

8. Efficacy and safety of levofloxacin in the context of other contemporary fluoroquinolones: a review.

Authors: Peter Ball
Journal: Curr Ther Res Clin Exp Date: 2003-11

Review 9. Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classes.

Authors: Françoise Van Bambeke; Paul M Tulkens
Journal: Drug Saf Date: 2009 Impact factor: 5.606

Review 10. An overview of harms associated with beta-lactam antimicrobials: where do the carbapenems fit in?

Authors: Robert C Owens
Journal: Crit Care Date: 2008-05-21 Impact factor: 9.097